Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Case report: Regression of Glioblastoma after flavivirus infection.
Garcez PP, Guasti A, Ventura N, Higa LM, Andreiuolo F, de Freitas GPA, Ribeiro LJ, Maia RA, de Lima SMB, de Souza Azevedo A, Schwarcz WD, Caride EC, Chimelli L, Dubois LG, Ferreira Júnior ODC, Tanuri A, Moura-Neto V, Niemeyer P. Garcez PP, et al. Among authors: de lima smb. Front Med (Lausanne). 2023 Jun 1;10:1192070. doi: 10.3389/fmed.2023.1192070. eCollection 2023. Front Med (Lausanne). 2023. PMID: 37324152 Free PMC article.
Safety and immunogenicity of 17DD attenuated yellow fever vaccine in howler monkeys (Alouatta spp.).
Tavares da Silva Fernandes A, Moreira SB, Gaspar LP, Simões M, Cajaraville ACDRA, Pereira RC, Gomes MPB, Linhares JHR, Santos VO, Santos RT, Amorim JF, Barros TADC, Melgaço JG, da Silva AMV, Fernandes CB, Tubarão LN, da Silva J, Caride EC, Borges MB, Guimarães RC, Marchevsky RS, de Lima SMB, Ano Bom APD, Neves PCDC, Pissinatti A, Freire MDS. Tavares da Silva Fernandes A, et al. Among authors: de lima smb. J Med Primatol. 2021 Feb;50(1):36-45. doi: 10.1111/jmp.12501. Epub 2020 Nov 20. J Med Primatol. 2021. PMID: 33219623
Effectiveness, safety, and immunogenicity of half dose ChAdOx1 nCoV-19 COVID-19 Vaccine: Viana project.
Valim V, Martins-Filho OA, Gouvea MDPG, Camacho LAB, Villela DAM, de Lima SMB, Azevedo AS, Neto LFP, Domingues CMAS, de Medeiros Junior NF, Moulaz IR, Dias LH, Miyamoto ST, Teixeira-Carvalho A, Mill JG; Half Dose ChAdOx Study Group. Valim V, et al. Among authors: de lima smb, de medeiros junior nf. Front Immunol. 2022 Aug 29;13:966416. doi: 10.3389/fimmu.2022.966416. eCollection 2022. Front Immunol. 2022. PMID: 36105814 Free PMC article. Clinical Trial.
Inactivated and Immunogenic SARS-CoV-2 for Safe Use in Immunoassays and as an Immunization Control for Non-Clinical Trials.
Gomes MPB, Linhares JHR, Dos Santos TP, Pereira RC, Santos RT, da Silva SA, Souza MCO, da Silva JFA, Trindade GF, Gomes VS, Barreto-Vieira DF, Carvalho MMVF, Ano Bom APD, Gardinali NR, Müller R, Alves NDS, Moura LDC, Neves PCDC, Esteves GS, Schwarcz WD, Missailidis S, Mendes YDS, de Lima SMB. Gomes MPB, et al. Among authors: de lima smb. Viruses. 2023 Jun 30;15(7):1486. doi: 10.3390/v15071486. Viruses. 2023. PMID: 37515173 Free PMC article.
Plaque Reduction Neutralization Test (PRNT) Accuracy in Evaluating Humoral Immune Response to SARS-CoV-2.
Horbach IS, de Souza Azevedo A, Schwarcz WD, Alves NDS, de Moura Dias B, Setatino BP, da Cruz Moura L, de Souza AF, Denani CB, da Silva SA, Pimentel TG, de Oliveira Silva Ferreira V, Azamor T, Ano Bom APD, da Penha Gomes Gouvea M, Mill JG, Valim V, Polese J, Campi-Azevedo AC, Peruhype-Magalhães V, Teixeira-Carvalho A, Martins-Filho OA, de Lima SMB, de Sousa Junior IP. Horbach IS, et al. Among authors: de lima smb. Diseases. 2024 Jan 18;12(1):29. doi: 10.3390/diseases12010029. Diseases. 2024. PMID: 38248380 Free PMC article.
Immune response induced by standard and fractional doses of 17DD yellow fever vaccine.
Abdala-Torres T, Campi-Azevedo AC, da Silva-Pereira RA, Dos Santos LI, Henriques PM, Costa-Rocha IA, Otta DA, Peruhype-Magalhães V, Teixeira-Carvalho A, Araújo MSS, Fernandes EG, Sato HK, Fantinato FFST, Domingues CMAS, Kallás EG, Tomiyama HTI, Lemos JAC, Coelho-Dos-Reis JG, de Lima SMB, Schwarcz WD, de Souza Azevedo A, Trindade GF, Ano Bom APD, da Silva AMV, Fernandes CB, Camacho LAB, de Sousa Maia ML; Collaborative Group for Studies of Yellow Fever Vaccine; Martins-Filho OA, do Antonelli LRDV. Abdala-Torres T, et al. Among authors: de lima smb. NPJ Vaccines. 2024 Mar 8;9(1):54. doi: 10.1038/s41541-024-00836-w. NPJ Vaccines. 2024. PMID: 38459059 Free PMC article.
Comprehensive landscape of neutralizing antibody and cell-mediated response elicited by the 1/5 fractional dose of 17DD-YF primary vaccination in adults.
Reis LR, Costa-Rocha IA, Abdala-Torres T, Campi-Azevedo AC, Peruhype-Magalhães V, Araújo MSS, Spezialli E, do Valle Antonelli LR, da Silva-Pereira RA, Almeida GG, Fernandes EG, Fantinato FFST, Domingues CMAS, Lemos MCF, Chieppe A, Lemos JAC, Coelho-Dos-Reis JG, de Lima SMB, de Souza Azevedo A, Schwarcz WD, Camacho LAB, de Lourdes de Sousa Maia M, de Noronha TG, Duault C, Rosenberg-Hasson Y, Teixeira-Carvalho A, Maecker HT, Martins-Filho OA; Collaborative Group for Studies of Yellow Fever Vaccine. Reis LR, et al. Among authors: de lima smb. Sci Rep. 2024 Apr 2;14(1):7709. doi: 10.1038/s41598-024-57645-3. Sci Rep. 2024. PMID: 38565882 Free PMC article.
Short-Lived Immunity After 17DD Yellow Fever Single Dose Indicates That Booster Vaccination May Be Required to Guarantee Protective Immunity in Children.
Campi-Azevedo AC, Reis LR, Peruhype-Magalhães V, Coelho-Dos-Reis JG, Antonelli LR, Fonseca CT, Costa-Pereira C, Souza-Fagundes EM, da Costa-Rocha IA, Mambrini JVM, Lemos JAC, Ribeiro JGL, Caldas IR, Camacho LAB, Maia MLS, de Noronha TG, de Lima SMB, Simões M, Freire MDS, Martins RM, Homma A, Tauil PL, Vasconcelos PFC, Romano APM, Domingues CM, Teixeira-Carvalho A, Martins-Filho OA. Campi-Azevedo AC, et al. Among authors: de noronha tg, de lima smb. Front Immunol. 2019 Sep 26;10:2192. doi: 10.3389/fimmu.2019.02192. eCollection 2019. Front Immunol. 2019. PMID: 31616412 Free PMC article. Clinical Trial.
Planned Yellow Fever Primary Vaccination Is Safe and Immunogenic in Patients With Autoimmune Diseases: A Prospective Non-interventional Study.
Valim V, Machado KLLL, Miyamoto ST, Pinto AD, Rocha PCM, Serrano EV, Dinis VG, Gouvêa SA, Dias JGF, Campi-Azevedo AC, Teixeira-Carvalho A, Peruhype-Magalhães V, da Costa-Rocha IA, de Lima SMB, Miranda EH, Trindade GF, Maia MLS, Gavi MBRO, da Silva LB, Duque RH, Gianordoli APE, Casagrande TZ, Oliveira KG, Moura BCDM, Nicole-Batista F, Rodrigues LC, Clemente TB, Magalhães ES, Bissoli MF, Gouvea MDPG, Pinto-Neto LFDS, Costa CZ, Giovelli RA, Brandão LR, Polito ETL, Koehlert IO, Borjaille BP, Pereira DB, Dias LH, Merlo DL, Genelhu LFF, Pretti FZ, Giacomin MDS, Burian APN, Fantinato FFST, Pileggi GS, da Mota LMH, Martins-Filho OA. Valim V, et al. Among authors: de lima smb. Front Immunol. 2020 Jul 17;11:1382. doi: 10.3389/fimmu.2020.01382. eCollection 2020. Front Immunol. 2020. PMID: 32765496 Free PMC article.
27 results